斯達外科手術 STAA 深 滬
已收盤 02-06 16:00:00 美东时间
17.58
+0.510
+2.99%
華盛通- 最 高17.725
- 今 開17.27
- 成交量 211.08万股
- 最 低 17.14
- 昨 收 17.07
- 總市值 8.74亿
- 52周最高 30.81
- 市盈率 靜 --
- 換手率 4.24%
- 52周最低 14.69
- 委 比 70.91%
- 總股本 4974.20万
- 歷史最高 163.08
- 量 比 1.85
- 振 幅 3.43%
- 歷史最低 4.48
- 每 手 1
- 風險率 4.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
STAAR Surgical Appoints Warren Foust And Deborah Andrews As Interim Co-CEOs, Effective Immediately
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction,
02-02 20:17
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs STAAR Surgical Company has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers effective February 1, 2026. The Board has formed a sear
02-02 20:02
Assessing Staar Surgical: Insights From 4 Financial Analysts
Ratings for Staar Surgical (NASDAQ:STAA) were provided by 4 analysts in the pas...
01-29 06:01
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Carvana and UnitedHealth on Wednesday. HIGHLIGHTS * Boeing BA.N : JP Morgan raises target price to $270
01-28 15:23
STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn
STAAR Surgical Company Files Initial Beneficial Ownership Statement for Director Richard T. LeBuhn STAAR Surgical Company has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing identifies Richard T. LeBuhn as a beneficial owner in the role
01-24 06:14
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
Staar Surgical reshapes board under new investor agreement
The latest update is out from Staar Surgical ( ($STAA) ). On January 14–15, 202...
01-15 22:49
STAAR Surgical, Broadwood Partners Sign Deal To Appoint Neal C. Bradsher, Richard T. LeBuhn, Christopher Wang To STAAR's Board, Effective Immediately
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners,
01-15 21:32
Staar Surgical shareholders reject merger, company stays independent
Staar Surgical ( ($STAA) ) has shared an announcement. On August 4, 2025, STAAR...
01-07 06:19
